Inhibition of Sat1 alleviates myocardial ischemia-reperfusion injury through regulation of ferroptosis via MAPK/ERK pathway
Zhou Liu,
Hongjin Chen,
Yingnan Song
и другие.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Ноя. 13, 2024
Introduction
Myocardial
ischemia-reperfusion
injury
(MIRI)
is
a
prevalent
complication
in
patients
with
myocardial
infarction.
The
pathological
mechanism
of
MIRI
remains
elusive.
Ferroptosis
plays
critical
role
MIRI.
This
study
aimed
to
investigate
the
spermidine/spermine
N1-acetyltransferase
1
(Sat1)
by
regulation
ferroptosis.
Methods
Rats
and
H9C2
cells
were
used
perform
model.
extent
damage
associated
changes
evaluated.
Protein
expression
was
detected
western
blot.
Then
we
observed
mitochondrial
morphology
measured
cell
viability
damage.
levels
lipid
peroxide
glutathione
measured,
reactive
oxygen
species
(ROS)
quantified.
Differentially
expressed
genes
(DEGs)
analyzed.
Moreover,
explore
Sat1
MIRI,
this
utilized
adeno-associated
virus
9
lentiviral
transduction
modulate
rats
cells,
respectively.
transcription
factor
that
regulates
predicated.
Luciferase
reporter
gene
experiment
conducted
reveal
potential
sites
Sox2
binding
Sat1.
Results
revealed
ferroptosis
involved
Through
bioinformatic
analysis,
identified
as
significant
which
has
been
reported
an
inducer
Our
results
showed
significantly
increased
Next,
inhibition
alleviated
suppressing
vivo
vitro
,
over-expression
promoted
via
activation
Furthermore,
its
interacting
enriched
several
signaling
pathways,
including
MAPK
pathway.
regulated
through
MAPK/ERK
it
found
can
suppress
at
transcriptional
level.
site
TAACAAAGGAA.
Conclusion
In
sum,
demonstrated
alleviate
regulating
pathway,
negatively
Sox2.
These
findings
suggested
may
serve
therapeutic
target
for
treatment
Язык: Английский
Notoginsenoside R1 Attenuates H/R Injury in H9c2 Cells by Maintaining Mitochondrial Homeostasis
Current Issues in Molecular Biology,
Год журнала:
2025,
Номер
47(1), С. 44 - 44
Опубликована: Янв. 10, 2025
Mitochondrial
homeostasis
is
crucial
for
maintaining
cellular
energy
production
and
preventing
oxidative
stress,
which
essential
overall
function
longevity.
damage
dysfunction
often
occur
concomitantly
in
myocardial
ischemia-reperfusion
injury
(MIRI).
Notoginsenoside
R1
(NGR1),
a
unique
saponin
from
the
traditional
Chinese
medicine
Panax
notoginseng,
has
been
shown
to
alleviate
MIRI
previous
studies,
though
its
precise
mechanism
remains
unclear.
This
study
aimed
elucidate
mechanisms
of
NGR1
mitochondrial
hypoxia/reoxygenation
(H/R)
H9c2
cells.
The
results
showed
that
pretreatment
effectively
increased
cell
survival
rates
post-H/R,
reduced
lactate
dehydrogenase
(LDH)
leakage,
mitigated
damage.
Further
investigation
into
mitochondria
revealed
alleviated
structural
damage,
improved
membrane
permeability
transition
pore
(mPTP)
persistence,
prevented
potential
(Δψm)
depolarization.
Additionally,
enhanced
ATP
levels,
activity
respiratory
chain
complexes
I-V
after
H/R,
excessive
reactive
oxygen
species
(mitoROS)
production,
thereby
protecting
function.
analysis
indicated
upregulated
expression
biogenesis-related
proteins
(PGC-1α,
Nrf1,
Nrf2)
fusion
(Opa1,
Mfn1,
Mfn2),
while
downregulating
fission
(Fis1,
Drp1)
reducing
autophagy
(mitophagy)
as
well
mitophagy-related
(Pink1,
Parkin,
BNIP3)
post-H/R.
Therefore,
this
can
maintain
by
regulating
mitophagy,
fission-fusion
dynamics,
biogenesis,
alleviating
H/R
cardiomyocytes.
Язык: Английский
Hypoferremia reduces long-term risk of major adverse cardiovascular events after STEMI by averting the myocardial reactive iron storm
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 15, 2025
ABSTRACT
Background
and
aims
Iron
deficiency
(ID)
is
common
in
patients
with
acute
STEMI.
ID
has
previously
been
associated
either
adverse
or
favourable
effects,
depending
on
the
definition
of
ID,
sampling
timepoint,
outcome
measures
follow-up
duration.
This
study
systematically
addresses
impact
long-term
outcomes
explores
underlying
mechanisms.
Methods
Patients
STEMI
(n=167)
were
followed
for
4.5
years
major
cardiovascular
events
(MACE),
including
new
HF
diagnosis,
recurrent
MI
cardiac
death.
markers
sampled
at
presentation
later
timepoints.
Myocardial
injury
was
assessed
by
CMR
2
days
6
months.
Mechanisms
clinical
findings
evaluated
a
mouse
model
MI.
Results
any
definition,
presentation.
Hypoferremia
(Tsat<20%
iron<13uM)
but
not
hypoferritinemia
(ferritin<100ug/L)
predicted
lower
risk
MACE.
troponin,
myocardial
T1,
LVESV
LVEDV
days,
salvage
status
from
hours
after
no
longer
In
mice,
rapidly
triggered
reactive
iron
storm,
early
LV
remodelling,
eventually
HF.
These
effects
averted
restriction.
Conclusions
reveals
that
hypoferremia
exerts
both
nonetheless
translate
into
better
outcomes.
research
reconciles
previous
seemingly
conflicting
reports.
It
also
highlights
potential
stepwise
approach
chelation
to
reduce
injury,
supplementation
promote
salvage.
Язык: Английский
Regulation of Iron Metabolism in Ferroptosis: from Mechanism Research to Clinical Translation
Journal of Pharmaceutical Analysis,
Год журнала:
2025,
Номер
unknown, С. 101304 - 101304
Опубликована: Апрель 1, 2025
Язык: Английский
Deciphering Oxidative Stress in Cardiovascular Disease Progression: A Blueprint for Mechanistic Understanding and Therapeutic Innovation
Antioxidants,
Год журнала:
2024,
Номер
14(1), С. 38 - 38
Опубликована: Дек. 31, 2024
Oxidative
stress
plays
a
pivotal
role
in
the
pathogenesis
and
progression
of
cardiovascular
diseases
(CVDs).
This
review
focuses
on
signaling
pathways
oxidative
during
development
CVDs,
delving
into
molecular
regulatory
networks
underlying
various
disease
stages,
particularly
apoptosis,
inflammation,
fibrosis,
metabolic
imbalance.
By
examining
dual
roles
influences
sex
differences
levels
susceptibility,
this
study
offers
comprehensive
understanding
diseases.
The
integrates
key
findings
from
current
research
three
ways.
First,
it
outlines
major
CVDs
associated
with
their
respective
pathways,
emphasizing
stress’s
central
pathology.
Second,
summarizes
protective
effects,
mechanisms
action,
animal
models
antioxidants,
offering
insights
future
drug
development.
Third,
discusses
applications,
advantages,
limitations,
potential
targets
gene
therapy
providing
foundation
for
novel
therapeutic
strategies.
These
tables
underscore
systematic
integrative
nature
while
theoretical
basis
precision
treatment
CVDs.
A
contribution
is
differential
effects
across
different
stages
addition
to
proposal
innovative,
multi-level
intervention
strategies,
which
open
new
avenues
system.
Язык: Английский